Xu Q - Search Results

1

Base editing of the mutated TERT promoter inhibits liver tumor growth.

Zhao G, Ma Q, Yang H, Jiang H, Xu Q, Luo S, Meng Z, Liu J, Zhu L, Lin Q, Li M, Fang J, Ma L, Qiu W, Mao Z, Lu Z. Zhao G, et al. Among authors: xu q. Hepatology. 2024 Jun 1;79(6):1310-1323. doi: 10.1097/HEP.0000000000000700. Epub 2023 Nov 28. Hepatology. 2024. PMID: 38016019

2

Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance.

Ma Q, Xu Q, Zhao J, Zhang W, Wang Q, Fang J, Lu Z, Liu J, Ma L. Ma Q, et al. Among authors: xu q. Cancer Lett. 2021 Nov 1;520:243-254. doi: 10.1016/j.canlet.2021.07.049. Epub 2021 Jul 31. Cancer Lett. 2021. PMID: 34339801

3

Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolin.

Xu Q, Gao B, Liu X, Zhang X, Wu L, Xing D, Ma L, Liu J. Xu Q, et al. Int J Clin Exp Pathol. 2022 May 15;15(5):206-214. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 35698637 Free PMC article.

4

Bioinformatics analysis identified RGS4 as a potential tumor promoter in glioma.

Wu L, Wang J, Zhao J, Yao R, Xu Q, Ma L, Liu J. Wu L, et al. Among authors: xu q. Pathol Res Pract. 2022 Dec;240:154225. doi: 10.1016/j.prp.2022.154225. Epub 2022 Nov 16. Pathol Res Pract. 2022. PMID: 36423402

5

The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation.

Ma Q, Jiang H, Ma L, Zhao G, Xu Q, Guo D, He N, Liu H, Meng Z, Liu J, Zhu L, Lin Q, Wu X, Li M, Luo S, Fang J, Lu Z. Ma Q, et al. Among authors: xu q. Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2209435120. doi: 10.1073/pnas.2209435120. Epub 2023 Apr 3. Proc Natl Acad Sci U S A. 2023. PMID: 37011206 Free PMC article.

6

UBC9 stabilizes PFKFB3 to promote aerobic glycolysis and proliferation of glioblastoma cells.

Meng Z, Bian X, Ma L, Zhang G, Ma Q, Xu Q, Liu J, Wang R, Lun J, Lin Q, Zhao G, Jiang H, Qiu W, Fang J, Lu Z. Meng Z, et al. Among authors: xu q. Int J Biochem Cell Biol. 2023 Dec;165:106491. doi: 10.1016/j.biocel.2023.106491. Epub 2023 Oct 28. Int J Biochem Cell Biol. 2023. PMID: 38149579

7

Interleukin‑22 alleviates arginine‑induced pancreatic acinar cell injury via the regulation of intracellular vesicle transport system: Evidence from proteomic analysis.

Xu Q, Fu X, Xiu Z, Yang H, Men X, Liu M, Xu C, Li B, Zhao S, Xu H. Xu Q, et al. Among authors: xu c, xu h. Exp Ther Med. 2023 Oct 26;26(6):578. doi: 10.3892/etm.2023.12277. eCollection 2023 Dec. Exp Ther Med. 2023. PMID: 38023358 Free PMC article.

8

Clinical application of machine learning-based pathomics signature of gastric atrophy.

Lan Y, Han B, Zhai T, Xu Q, Li Z, Liu M, Xue Y, Xu H. Lan Y, et al. Among authors: xu q, xu h. Front Oncol. 2024 Feb 27;14:1289265. doi: 10.3389/fonc.2024.1289265. eCollection 2024. Front Oncol. 2024. PMID: 38476364 Free PMC article.

9

Interleukin-22 Alleviates Caerulein-Induced Acute Pancreatitis by Activating AKT/mTOR Pathway.

Fu X, Xiu Z, Xu Q, Yue R, Xu H. Fu X, et al. Among authors: xu q, xu h. Dig Dis Sci. 2024 May;69(5):1691-1700. doi: 10.1007/s10620-024-08360-6. Epub 2024 Mar 11. Dig Dis Sci. 2024. PMID: 38466463 Free PMC article.

10

Exploring the pathogenesis of chronic atrophic gastritis with atherosclerosis via microarray data analysis.

Men X, Shi X, Xu Q, Liu M, Yang H, Wang L, Men X, Xu H. Men X, et al. Among authors: xu q, xu h. Medicine (Baltimore). 2024 Apr 19;103(16):e37798. doi: 10.1097/MD.0000000000037798. Medicine (Baltimore). 2024. PMID: 38640295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,380 results

Search Page

Filters